AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,829 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr | ₹4,109 Cr |
What is the latest Total Liabilities ratio of AJANTA PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹4,829 Cr |
| Mar2024 | ₹4,504 Cr |
| Mar2023 | ₹4,705 Cr |
| Mar2022 | ₹4,197 Cr |
| Mar2021 | ₹4,109 Cr |
How is Total Liabilities of AJANTA PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,829 Cr | 7.21 | |
| Mar2024 | ₹4,504 Cr | -4.27 | |
| Mar2023 | ₹4,705 Cr | 12.10 | |
| Mar2022 | ₹4,197 Cr | 2.14 | |
| Mar2021 | ₹4,109 Cr | - | |
Compare Total Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹36,642.5 Cr | -1% | 4.3% | 22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -1% |
4.3% |
22.5% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses